NCT06903364

Brief Summary

This study is a prospective study of patients with diabetes. The main objective of this study is to investigate the relationship between lifestyle and long-term complications in diabetic patients, which will help to screen out the high-risk group at an early stage and provide scientific advice for the prevention of complications in diabetic patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
24mo left

Started Aug 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Aug 2024Mar 2028

Study Start

First participant enrolled

August 1, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 19, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 30, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2028

Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

3.7 years

First QC Date

March 19, 2025

Last Update Submit

April 7, 2026

Conditions

Diabetes Mellitus

Outcome Measures

Primary Outcomes (1)

  • Number of Participants with Diabetes Complications

    From enrollment to the end of the three-year follow-up

Study Arms (2)

Group without complications

Complication group

Eligibility Criteria

Age20 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Diabetic patients with or without complications

You may qualify if:

  • Patients with a normative diagnosis of type 2 diabetes
  • Age ≥20 years old, regardless of gender
  • From January 2022 to December 2025, he was treated in Nanfang Hospital

You may not qualify if:

  • In the acute infection phase
  • The researchers judged that it was not suitable to participate in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NanFang Hospital of Southern Medical University

Guangzhou, China

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Central Study Contacts

Meng-Chen Zou

CONTACT

+86186 8842 3756zoumc@smu.edu.cn

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2025

First Posted

March 30, 2025

Study Start

August 1, 2024

Primary Completion (Estimated)

March 30, 2028

Study Completion (Estimated)

March 30, 2028

Last Updated

April 8, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)